

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 5.22677326 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.70304857 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.70304857 |
| 4 | proteasome assembly (GO:0043248) | 4.32257230 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.26105223 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.23106444 |
| 7 | fatty acid elongation (GO:0030497) | 4.19229201 |
| 8 | glycolipid catabolic process (GO:0019377) | 3.83977132 |
| 9 | pentose-phosphate shunt (GO:0006098) | 3.80406482 |
| 10 | barbed-end actin filament capping (GO:0051016) | 3.56752039 |
| 11 | signal peptide processing (GO:0006465) | 3.56698332 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.56283536 |
| 13 | regulation of superoxide anion generation (GO:0032928) | 3.46285150 |
| 14 | amino sugar catabolic process (GO:0046348) | 3.45895945 |
| 15 | ribosomal small subunit biogenesis (GO:0042274) | 3.42428207 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.42373973 |
| 17 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.37594611 |
| 18 | ceramide catabolic process (GO:0046514) | 3.37468732 |
| 19 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34924148 |
| 20 | pinocytosis (GO:0006907) | 3.31948759 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 3.30686895 |
| 22 | glucose catabolic process (GO:0006007) | 3.27402945 |
| 23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.26454864 |
| 24 | regulation of metalloenzyme activity (GO:0048552) | 3.24289239 |
| 25 | protein targeting to ER (GO:0045047) | 3.24233113 |
| 26 | protein localization to endosome (GO:0036010) | 3.22091224 |
| 27 | viral transcription (GO:0019083) | 3.20166336 |
| 28 | oligosaccharide catabolic process (GO:0009313) | 3.18999459 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.18580989 |
| 30 | L-methionine salvage (GO:0071267) | 3.15962814 |
| 31 | L-methionine biosynthetic process (GO:0071265) | 3.15962814 |
| 32 | amino acid salvage (GO:0043102) | 3.15962814 |
| 33 | * protein localization to endoplasmic reticulum (GO:0070972) | 3.14929819 |
| 34 | translational termination (GO:0006415) | 3.13935925 |
| 35 | aldehyde catabolic process (GO:0046185) | 3.12533600 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.10390930 |
| 37 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.09786949 |
| 38 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.06334087 |
| 39 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.05602827 |
| 40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.99926657 |
| 41 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.99926657 |
| 42 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.99870642 |
| 43 | protein retention in ER lumen (GO:0006621) | 2.99073686 |
| 44 | DNA deamination (GO:0045006) | 2.99034699 |
| 45 | response to thyroid hormone (GO:0097066) | 2.99000748 |
| 46 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.98265107 |
| 47 | negative regulation of ligase activity (GO:0051352) | 2.97520818 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.97520818 |
| 49 | pentose metabolic process (GO:0019321) | 2.97111259 |
| 50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.96945961 |
| 51 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.96945961 |
| 52 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.96945961 |
| 53 | maturation of SSU-rRNA (GO:0030490) | 2.95301187 |
| 54 | sphingolipid catabolic process (GO:0030149) | 2.95030297 |
| 55 | membrane lipid catabolic process (GO:0046466) | 2.94796958 |
| 56 | cholesterol biosynthetic process (GO:0006695) | 2.92388876 |
| 57 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.92342434 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.92296503 |
| 59 | NADH metabolic process (GO:0006734) | 2.87348407 |
| 60 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.86704943 |
| 61 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.83022446 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 2.83022446 |
| 63 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.82770414 |
| 64 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.82770414 |
| 65 | ribosomal large subunit biogenesis (GO:0042273) | 2.82353307 |
| 66 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.81719331 |
| 67 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.77360373 |
| 68 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.75589237 |
| 69 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.75202489 |
| 70 | glucose 6-phosphate metabolic process (GO:0051156) | 2.75006495 |
| 71 | protein neddylation (GO:0045116) | 2.73154167 |
| 72 | translational elongation (GO:0006414) | 2.72488698 |
| 73 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.72181791 |
| 74 | regulation of cholesterol storage (GO:0010885) | 2.71890951 |
| 75 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.71451947 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.71237113 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.71237113 |
| 78 | low-density lipoprotein particle clearance (GO:0034383) | 2.70704166 |
| 79 | platelet dense granule organization (GO:0060155) | 2.70308234 |
| 80 | response to interferon-beta (GO:0035456) | 2.69027004 |
| 81 | * negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68755488 |
| 82 | translation (GO:0006412) | 2.68473128 |
| 83 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.68260318 |
| 84 | cellular copper ion homeostasis (GO:0006878) | 2.68209132 |
| 85 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.67134040 |
| 86 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.67134040 |
| 87 | NADH dehydrogenase complex assembly (GO:0010257) | 2.67134040 |
| 88 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.65653723 |
| 89 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.65260882 |
| 90 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.64879817 |
| 91 | amyloid precursor protein metabolic process (GO:0042982) | 2.64272361 |
| 92 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.64124139 |
| 93 | amyloid precursor protein catabolic process (GO:0042987) | 2.62298690 |
| 94 | regulation of mononuclear cell migration (GO:0071675) | 2.62289741 |
| 95 | regulation of superoxide metabolic process (GO:0090322) | 2.61883830 |
| 96 | hyaluronan catabolic process (GO:0030214) | 2.61268055 |
| 97 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60690583 |
| 98 | sterol biosynthetic process (GO:0016126) | 2.60627486 |
| 99 | thioester biosynthetic process (GO:0035384) | 2.59443443 |
| 100 | acyl-CoA biosynthetic process (GO:0071616) | 2.59443443 |
| 101 | purine nucleobase biosynthetic process (GO:0009113) | 2.59170577 |
| 102 | respiratory electron transport chain (GO:0022904) | 2.58746763 |
| 103 | formation of translation preinitiation complex (GO:0001731) | 2.58661593 |
| 104 | L-phenylalanine catabolic process (GO:0006559) | 2.57415969 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.57415969 |
| 106 | cyclooxygenase pathway (GO:0019371) | 2.56894113 |
| 107 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.55992592 |
| 108 | pyrimidine nucleoside salvage (GO:0043097) | 2.54924474 |
| 109 | pyrimidine-containing compound salvage (GO:0008655) | 2.54924474 |
| 110 | viral life cycle (GO:0019058) | 2.54920918 |
| 111 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54779324 |
| 112 | electron transport chain (GO:0022900) | 2.52124986 |
| 113 | pantothenate metabolic process (GO:0015939) | 2.51916394 |
| 114 | regulation of cellular amine metabolic process (GO:0033238) | 2.51876669 |
| 115 | eosinophil chemotaxis (GO:0048245) | 2.51478324 |
| 116 | respiratory chain complex IV assembly (GO:0008535) | 2.51417609 |
| 117 | proline biosynthetic process (GO:0006561) | 2.50168537 |
| 118 | apoptotic cell clearance (GO:0043277) | 2.49754227 |
| 119 | oxidative phosphorylation (GO:0006119) | 2.49589423 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 2.49448476 |
| 121 | L-serine metabolic process (GO:0006563) | 2.49179097 |
| 122 | GDP-mannose metabolic process (GO:0019673) | 2.48738275 |
| 123 | translational initiation (GO:0006413) | 2.48253976 |
| 124 | cofactor catabolic process (GO:0051187) | 2.48116805 |
| 125 | * endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.47983058 |
| 126 | GPI anchor biosynthetic process (GO:0006506) | 2.47851648 |
| 127 | L-phenylalanine metabolic process (GO:0006558) | 2.47447945 |
| 128 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.47447945 |
| 129 | transferrin transport (GO:0033572) | 2.46404558 |
| 130 | cellular response to arsenic-containing substance (GO:0071243) | 2.46393484 |
| 131 | positive regulation of ligase activity (GO:0051351) | 2.45978258 |
| 132 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.45952096 |
| 133 | keratan sulfate catabolic process (GO:0042340) | 2.45420259 |
| 134 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.44680589 |
| 135 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.44680589 |
| 136 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.44387309 |
| 137 | nuclear envelope reassembly (GO:0031468) | 2.44097524 |
| 138 | mitotic nuclear envelope reassembly (GO:0007084) | 2.44097524 |
| 139 | chaperone-mediated protein transport (GO:0072321) | 2.42514517 |
| 140 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.41421999 |
| 141 | decidualization (GO:0046697) | 2.41411477 |
| 142 | phagosome maturation (GO:0090382) | 2.38727454 |
| 143 | protein complex biogenesis (GO:0070271) | 2.37903660 |
| 144 | rRNA modification (GO:0000154) | 2.35884942 |
| 145 | regulation of podosome assembly (GO:0071801) | 2.35795058 |
| 146 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.35514171 |
| 147 | response to peptidoglycan (GO:0032494) | 2.35384908 |
| 148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.35124430 |
| 149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.34900273 |
| 150 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.34234933 |
| 151 | branched-chain amino acid catabolic process (GO:0009083) | 2.34040225 |
| 152 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33761158 |
| 153 | negative regulation of mitochondrion organization (GO:0010823) | 2.33394753 |
| 154 | very long-chain fatty acid metabolic process (GO:0000038) | 2.33261860 |
| 155 | glycoside metabolic process (GO:0016137) | 2.33136764 |
| 156 | acyl-CoA metabolic process (GO:0006637) | 2.32705969 |
| 157 | thioester metabolic process (GO:0035383) | 2.32705969 |
| 158 | NADPH regeneration (GO:0006740) | 2.32167821 |
| 159 | nucleotide salvage (GO:0043173) | 2.32003788 |
| 160 | valine metabolic process (GO:0006573) | 2.31820986 |
| 161 | cellular protein complex disassembly (GO:0043624) | 2.30567121 |
| 162 | nucleobase biosynthetic process (GO:0046112) | 2.30550647 |
| 163 | tricarboxylic acid cycle (GO:0006099) | 2.28454557 |
| 164 | 7-methylguanosine mRNA capping (GO:0006370) | 2.28078725 |
| 165 | sphingosine metabolic process (GO:0006670) | 2.27604502 |
| 166 | cullin deneddylation (GO:0010388) | 2.27258174 |
| 167 | serine family amino acid biosynthetic process (GO:0009070) | 2.27113302 |
| 168 | NIK/NF-kappaB signaling (GO:0038061) | 2.25289387 |
| 169 | purine nucleotide salvage (GO:0032261) | 2.24716436 |
| 170 | trivalent inorganic cation transport (GO:0072512) | 2.22863242 |
| 171 | ferric iron transport (GO:0015682) | 2.22863242 |
| 172 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.22278566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.76925789 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.55409121 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.46550414 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.37952615 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.36210518 |
| 6 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15019654 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.14404746 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.10953751 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.93167733 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.88480198 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.84500343 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.71807333 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.71183610 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.69913891 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.49085919 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.44735187 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.38312435 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.27659227 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.27179320 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.22474347 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.19804590 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14144932 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.14044931 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.13256780 |
| 25 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12848716 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06666294 |
| 27 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.06120379 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05067068 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04587164 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02721540 |
| 31 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.91948826 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.90822333 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85266722 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.83069737 |
| 35 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81344856 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80590504 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.79987765 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.79858504 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.79807819 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79284239 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76703943 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76443516 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73260704 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.70633257 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.69522610 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.69077839 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.66548489 |
| 48 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.63703612 |
| 49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62866772 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62708138 |
| 51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.61831639 |
| 52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60797979 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.60737844 |
| 54 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58436204 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53426728 |
| 56 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.53192433 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52408421 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49026450 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48892910 |
| 60 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.45299266 |
| 61 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.44577705 |
| 62 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.43175033 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42302056 |
| 64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42067914 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41032430 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39969550 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39641044 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39575665 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39153925 |
| 70 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32049758 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31404973 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30140488 |
| 73 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29877493 |
| 74 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27927611 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27556974 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.27362822 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26920019 |
| 78 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24460368 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22964493 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.22761479 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21677530 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20777349 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19148852 |
| 84 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.18310725 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17377535 |
| 86 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15355261 |
| 87 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14056749 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13895191 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13807688 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.13713693 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13289184 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13045738 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12664237 |
| 94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11394901 |
| 95 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09728683 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09703456 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09248523 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.08577933 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.06761666 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05624599 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04787435 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04670228 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04553195 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 1.04524142 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04324788 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03519555 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03322604 |
| 108 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03173591 |
| 109 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02971671 |
| 110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02543105 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01891306 |
| 112 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01258157 |
| 113 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00088419 |
| 114 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99188713 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99078394 |
| 116 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97526027 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96569262 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94139351 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94099018 |
| 120 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.93976979 |
| 121 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93214646 |
| 122 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92858564 |
| 123 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92653728 |
| 124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.92054798 |
| 125 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.90736372 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90663936 |
| 127 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89826635 |
| 128 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89369091 |
| 129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87431727 |
| 130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.87109861 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86982124 |
| 132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86762333 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86375706 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86217874 |
| 135 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85343252 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85303144 |
| 137 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85043551 |
| 138 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82219898 |
| 139 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81146254 |
| 140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80967100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.06584824 |
| 2 | MP0003186_abnormal_redox_activity | 3.25746798 |
| 3 | MP0003724_increased_susceptibility_to | 2.76737899 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 2.50915660 |
| 5 | MP0009840_abnormal_foam_cell | 2.50052569 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.49753328 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.44057968 |
| 8 | MP0005360_urolithiasis | 2.31313480 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.29594508 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.29159109 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.19072204 |
| 12 | MP0003075_altered_response_to | 2.16315383 |
| 13 | MP0003303_peritoneal_inflammation | 2.11445316 |
| 14 | MP0009785_altered_susceptibility_to | 2.08705947 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.07751708 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.04237032 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.03480327 |
| 18 | MP0006082_CNS_inflammation | 2.02322378 |
| 19 | MP0004147_increased_porphyrin_level | 1.97516607 |
| 20 | MP0003195_calcinosis | 1.96238622 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 1.89714541 |
| 22 | MP0000604_amyloidosis | 1.88135939 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.84803976 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.81948387 |
| 25 | MP0001764_abnormal_homeostasis | 1.81712079 |
| 26 | MP0005365_abnormal_bile_salt | 1.76605706 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.76566007 |
| 28 | MP0006054_spinal_hemorrhage | 1.72042762 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.72002374 |
| 30 | MP0001542_abnormal_bone_strength | 1.71343692 |
| 31 | MP0005165_increased_susceptibility_to | 1.70363727 |
| 32 | MP0002132_abnormal_respiratory_system | 1.66082162 |
| 33 | MP0009379_abnormal_foot_pigmentation | 1.64401910 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.62966491 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.61906829 |
| 36 | MP0005025_abnormal_response_to | 1.60616311 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.53389454 |
| 38 | MP0002419_abnormal_innate_immunity | 1.52014363 |
| 39 | MP0005332_abnormal_amino_acid | 1.49097253 |
| 40 | MP0005671_abnormal_response_to | 1.49077123 |
| 41 | MP0003436_decreased_susceptibility_to | 1.48927233 |
| 42 | MP0005408_hypopigmentation | 1.46819221 |
| 43 | MP0003693_abnormal_embryo_hatching | 1.46179626 |
| 44 | MP0003718_maternal_effect | 1.45034249 |
| 45 | MP0003329_amyloid_beta_deposits | 1.43943902 |
| 46 | MP0001853_heart_inflammation | 1.41781530 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.41312202 |
| 48 | MP0003011_delayed_dark_adaptation | 1.38920297 |
| 49 | MP0005275_abnormal_skin_tensile | 1.36639091 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.36090059 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.33874002 |
| 52 | MP0001849_ear_inflammation | 1.32051056 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.31770072 |
| 54 | MP0008469_abnormal_protein_level | 1.31302777 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.31078322 |
| 56 | MP0004510_myositis | 1.30748490 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.30600465 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.28387630 |
| 59 | MP0000685_abnormal_immune_system | 1.28203720 |
| 60 | MP0000920_abnormal_myelination | 1.27519224 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.27131134 |
| 62 | MP0005451_abnormal_body_composition | 1.25817257 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.25075001 |
| 64 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23632715 |
| 65 | MP0000343_altered_response_to | 1.20643621 |
| 66 | MP0008004_abnormal_stomach_pH | 1.20421515 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.20391927 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.19625431 |
| 69 | MP0008260_abnormal_autophagy | 1.19416813 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.19180041 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.19180041 |
| 72 | MP0000358_abnormal_cell_content/ | 1.18746840 |
| 73 | MP0003448_altered_tumor_morphology | 1.17960886 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.17717344 |
| 75 | MP0002723_abnormal_immune_serum | 1.17376472 |
| 76 | MP0009697_abnormal_copulation | 1.16662452 |
| 77 | MP0005083_abnormal_biliary_tract | 1.16275158 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 1.13988506 |
| 79 | MP0002933_joint_inflammation | 1.12573945 |
| 80 | MP0001216_abnormal_epidermal_layer | 1.12277389 |
| 81 | MP0002452_abnormal_antigen_presenting | 1.11834326 |
| 82 | MP0002796_impaired_skin_barrier | 1.11282949 |
| 83 | MP0005670_abnormal_white_adipose | 1.11065165 |
| 84 | MP0001666_abnormal_nutrient_absorption | 1.10445277 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 1.10066627 |
| 86 | MP0001661_extended_life_span | 1.09953356 |
| 87 | MP0004381_abnormal_hair_follicle | 1.09066823 |
| 88 | MP0005166_decreased_susceptibility_to | 1.07953558 |
| 89 | MP0002420_abnormal_adaptive_immunity | 1.07843768 |
| 90 | MP0000609_abnormal_liver_physiology | 1.07343891 |
| 91 | MP0001819_abnormal_immune_cell | 1.06742476 |
| 92 | MP0009278_abnormal_bone_marrow | 1.06095136 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 1.05649189 |
| 94 | MP0005164_abnormal_response_to | 1.04673803 |
| 95 | MP0001845_abnormal_inflammatory_respons | 1.04557603 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.04422936 |
| 97 | MP0009763_increased_sensitivity_to | 1.03718952 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 1.03047231 |
| 99 | MP0001800_abnormal_humoral_immune | 1.02919970 |
| 100 | MP0002006_tumorigenesis | 1.02333925 |
| 101 | MP0004272_abnormal_basement_membrane | 1.01874544 |
| 102 | MP0001243_abnormal_dermal_layer | 1.01854513 |
| 103 | MP0009764_decreased_sensitivity_to | 1.00901259 |
| 104 | MP0005387_immune_system_phenotype | 0.99020865 |
| 105 | MP0001790_abnormal_immune_system | 0.99020865 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.97635384 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.96265372 |
| 108 | MP0002060_abnormal_skin_morphology | 0.95697547 |
| 109 | MP0002405_respiratory_system_inflammati | 0.93608820 |
| 110 | MP0003300_gastrointestinal_ulcer | 0.92164552 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.91600892 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.91586525 |
| 113 | MP0002254_reproductive_system_inflammat | 0.91477530 |
| 114 | MP0005501_abnormal_skin_physiology | 0.91118282 |
| 115 | MP0000858_altered_metastatic_potential | 0.90890372 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.90505963 |
| 117 | MP0004947_skin_inflammation | 0.90186192 |
| 118 | MP0004233_abnormal_muscle_weight | 0.88662717 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.88317062 |
| 120 | MP0003786_premature_aging | 0.88036542 |
| 121 | MP0000490_abnormal_crypts_of | 0.87510137 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.87369837 |
| 123 | MP0003763_abnormal_thymus_physiology | 0.86159239 |
| 124 | MP0001727_abnormal_embryo_implantation | 0.85681424 |
| 125 | MP0005023_abnormal_wound_healing | 0.85269502 |
| 126 | MP0000716_abnormal_immune_system | 0.84239130 |
| 127 | MP0004019_abnormal_vitamin_homeostasis | 0.83383078 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.81437765 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.79089361 |
| 130 | MP0008007_abnormal_cellular_replicative | 0.78838198 |
| 131 | MP0001881_abnormal_mammary_gland | 0.78761388 |
| 132 | MP0004858_abnormal_nervous_system | 0.77784648 |
| 133 | MP0002090_abnormal_vision | 0.75710797 |
| 134 | MP0003795_abnormal_bone_structure | 0.73895101 |
| 135 | MP0005390_skeleton_phenotype | 0.71665842 |
| 136 | MP0000371_diluted_coat_color | 0.68859673 |
| 137 | MP0005330_cardiomyopathy | 0.68014247 |
| 138 | MP0010771_integument_phenotype | 0.67508146 |
| 139 | MP0000678_abnormal_parathyroid_gland | 0.65316808 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.65086514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.66045132 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.66045132 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.66045132 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.20056871 |
| 5 | Abnormality of glycolysis (HP:0004366) | 3.97364170 |
| 6 | Increased serum pyruvate (HP:0003542) | 3.97364170 |
| 7 | Dysostosis multiplex (HP:0000943) | 3.93892453 |
| 8 | Loss of speech (HP:0002371) | 3.65728403 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.57116721 |
| 10 | Hepatic necrosis (HP:0002605) | 3.56904078 |
| 11 | Axonal loss (HP:0003447) | 3.53084314 |
| 12 | Vertebral compression fractures (HP:0002953) | 3.49215401 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.41009872 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.31936225 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.30156810 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.29093405 |
| 17 | Acute encephalopathy (HP:0006846) | 3.13647815 |
| 18 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.10921170 |
| 19 | Nuclear cataract (HP:0100018) | 3.10881801 |
| 20 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.05527144 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.05527144 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.05527144 |
| 23 | Increased CSF lactate (HP:0002490) | 3.04187392 |
| 24 | Hypokinesia (HP:0002375) | 3.01389355 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00222445 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 2.97785682 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 2.94998385 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 2.93264993 |
| 29 | Mucopolysacchariduria (HP:0008155) | 2.90663884 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90663884 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 2.88362697 |
| 32 | Abnormal number of erythroid precursors (HP:0012131) | 2.86752130 |
| 33 | Parakeratosis (HP:0001036) | 2.84505980 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.84461339 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 2.84423018 |
| 36 | Cholecystitis (HP:0001082) | 2.84423018 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.83753737 |
| 38 | Progressive neurologic deterioration (HP:0002344) | 2.80485228 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.80088017 |
| 40 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.76869021 |
| 41 | Myocardial infarction (HP:0001658) | 2.72333961 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70061121 |
| 43 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.65327406 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.64476850 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.62816982 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.62816982 |
| 47 | Increased muscle lipid content (HP:0009058) | 2.61654037 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.61229949 |
| 49 | Cerebral edema (HP:0002181) | 2.57518869 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.57443243 |
| 51 | Increased serum lactate (HP:0002151) | 2.55497085 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.55043150 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.53495022 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53495022 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.53100812 |
| 56 | Increased intramyocellular lipid droplets (HP:0012240) | 2.51104854 |
| 57 | Rough bone trabeculation (HP:0100670) | 2.50731778 |
| 58 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.50438556 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.49752948 |
| 60 | Nausea (HP:0002018) | 2.43013060 |
| 61 | Lactic acidosis (HP:0003128) | 2.41301306 |
| 62 | Lethargy (HP:0001254) | 2.33861546 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.32166719 |
| 64 | Aplastic anemia (HP:0001915) | 2.31394722 |
| 65 | CNS demyelination (HP:0007305) | 2.29149946 |
| 66 | Hypobetalipoproteinemia (HP:0003563) | 2.28974615 |
| 67 | Intrahepatic cholestasis (HP:0001406) | 2.28801545 |
| 68 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27654443 |
| 69 | Respiratory failure (HP:0002878) | 2.27490957 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27098735 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.26653696 |
| 72 | Exertional dyspnea (HP:0002875) | 2.26404455 |
| 73 | Disinhibition (HP:0000734) | 2.26146432 |
| 74 | Spastic paraparesis (HP:0002313) | 2.25892982 |
| 75 | Upper motor neuron abnormality (HP:0002127) | 2.24809963 |
| 76 | Cerebral inclusion bodies (HP:0100314) | 2.24164167 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.23985562 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.22989806 |
| 79 | Reticulocytopenia (HP:0001896) | 2.22816677 |
| 80 | Steatorrhea (HP:0002570) | 2.22583979 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.22567616 |
| 82 | Glycosuria (HP:0003076) | 2.22567616 |
| 83 | Prolonged neonatal jaundice (HP:0006579) | 2.22311317 |
| 84 | Xanthomatosis (HP:0000991) | 2.22005306 |
| 85 | Poor head control (HP:0002421) | 2.21894522 |
| 86 | Abnormality of glycine metabolism (HP:0010895) | 2.21393378 |
| 87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21393378 |
| 88 | Abnormal trabecular bone morphology (HP:0100671) | 2.21132819 |
| 89 | Purpura (HP:0000979) | 2.20865639 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.20699065 |
| 91 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20451548 |
| 92 | Diminished motivation (HP:0000745) | 2.20122901 |
| 93 | Amyloidosis (HP:0011034) | 2.18393347 |
| 94 | Apathy (HP:0000741) | 2.18158304 |
| 95 | Methylmalonic aciduria (HP:0012120) | 2.17721215 |
| 96 | Petechiae (HP:0000967) | 2.17599100 |
| 97 | Sparse eyelashes (HP:0000653) | 2.16539004 |
| 98 | Abnormal hemoglobin (HP:0011902) | 2.15811258 |
| 99 | Macrocytic anemia (HP:0001972) | 2.15359475 |
| 100 | Abnormality of macrophages (HP:0004311) | 2.13317507 |
| 101 | Abnormality of alanine metabolism (HP:0010916) | 2.11509767 |
| 102 | Hyperalaninemia (HP:0003348) | 2.11509767 |
| 103 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.11509767 |
| 104 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11200227 |
| 105 | Prolonged partial thromboplastin time (HP:0003645) | 2.09244210 |
| 106 | Respiratory difficulties (HP:0002880) | 2.07793684 |
| 107 | Fasciculations (HP:0002380) | 2.07176801 |
| 108 | Beaking of vertebral bodies (HP:0004568) | 2.04127778 |
| 109 | Premature rupture of membranes (HP:0001788) | 2.03535128 |
| 110 | Mutism (HP:0002300) | 2.02960422 |
| 111 | Osteolytic defects of the hand bones (HP:0009699) | 2.00297885 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00297885 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 1.99924835 |
| 114 | Cardiomegaly (HP:0001640) | 1.99850437 |
| 115 | Abnormality of serum amino acid levels (HP:0003112) | 1.97835678 |
| 116 | Bone pain (HP:0002653) | 1.96846105 |
| 117 | Pancytopenia (HP:0001876) | 1.96710359 |
| 118 | Trismus (HP:0000211) | 1.96394365 |
| 119 | Hyperglycinuria (HP:0003108) | 1.95824970 |
| 120 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94349587 |
| 121 | Abnormality of methionine metabolism (HP:0010901) | 1.94227222 |
| 122 | Hyperglycinemia (HP:0002154) | 1.93307311 |
| 123 | Fat malabsorption (HP:0002630) | 1.93062213 |
| 124 | Nonimmune hydrops fetalis (HP:0001790) | 1.93040850 |
| 125 | Increased serum ferritin (HP:0003281) | 1.92482869 |
| 126 | Hyperammonemia (HP:0001987) | 1.92311952 |
| 127 | Exercise intolerance (HP:0003546) | 1.92238338 |
| 128 | Leukodystrophy (HP:0002415) | 1.92194908 |
| 129 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92136842 |
| 130 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92136842 |
| 131 | Abnormal protein glycosylation (HP:0012346) | 1.92136842 |
| 132 | Abnormal glycosylation (HP:0012345) | 1.92136842 |
| 133 | Thrombocytosis (HP:0001894) | 1.91959592 |
| 134 | Opisthotonus (HP:0002179) | 1.91178059 |
| 135 | Neuronal loss in central nervous system (HP:0002529) | 1.91030713 |
| 136 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.90925499 |
| 137 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90579342 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.90474783 |
| 139 | Short nail (HP:0001799) | 1.90140622 |
| 140 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89938095 |
| 141 | Recurrent abscess formation (HP:0002722) | 1.89439437 |
| 142 | Achilles tendon contracture (HP:0001771) | 1.89325251 |
| 143 | Respiratory distress (HP:0002098) | 1.88451199 |
| 144 | Personality changes (HP:0000751) | 1.87312510 |
| 145 | Tetraparesis (HP:0002273) | 1.87057149 |
| 146 | Autoamputation (HP:0001218) | 1.85473901 |
| 147 | Distal upper limb amyotrophy (HP:0007149) | 1.84551172 |
| 148 | Upper limb amyotrophy (HP:0009129) | 1.84551172 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.84255569 |
| 150 | Multiple enchondromatosis (HP:0005701) | 1.81672723 |
| 151 | Recurrent bacterial skin infections (HP:0005406) | 1.81039869 |
| 152 | Birth length less than 3rd percentile (HP:0003561) | 1.80358912 |
| 153 | Abnormality of the Achilles tendon (HP:0005109) | 1.80072996 |
| 154 | Neoplasm of head and neck (HP:0012288) | 1.77039567 |
| 155 | Esophageal neoplasm (HP:0100751) | 1.77039567 |
| 156 | Glomerulonephritis (HP:0000099) | 1.76105325 |
| 157 | Testicular atrophy (HP:0000029) | 1.74461892 |
| 158 | Dementia (HP:0000726) | 1.73550445 |
| 159 | Pathologic fracture (HP:0002756) | 1.73435863 |
| 160 | Paraparesis (HP:0002385) | 1.71407258 |
| 161 | Hypertensive crisis (HP:0100735) | 1.70692802 |
| 162 | Hand muscle atrophy (HP:0009130) | 1.70567006 |
| 163 | Hypertriglyceridemia (HP:0002155) | 1.69108681 |
| 164 | Tongue fasciculations (HP:0001308) | 1.65189588 |
| 165 | Cervical subluxation (HP:0003308) | 1.63563041 |
| 166 | Chronic obstructive pulmonary disease (HP:0006510) | 1.62925310 |
| 167 | Obstructive lung disease (HP:0006536) | 1.62925310 |
| 168 | Abnormality of iron homeostasis (HP:0011031) | 1.62840064 |
| 169 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.60329156 |
| 170 | Multiple lipomas (HP:0001012) | 1.59801881 |
| 171 | Abnormality of the anterior horn cell (HP:0006802) | 1.59446264 |
| 172 | Degeneration of anterior horn cells (HP:0002398) | 1.59446264 |
| 173 | Supranuclear gaze palsy (HP:0000605) | 1.58467821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.52833252 |
| 2 | STK16 | 3.36943193 |
| 3 | BUB1 | 3.17915677 |
| 4 | MST4 | 2.98947929 |
| 5 | EIF2AK1 | 2.77636153 |
| 6 | PIM2 | 2.72862405 |
| 7 | PBK | 2.71503005 |
| 8 | TESK2 | 2.63210426 |
| 9 | BCKDK | 2.54709698 |
| 10 | VRK2 | 2.44367043 |
| 11 | EIF2AK3 | 2.44213448 |
| 12 | PAK4 | 2.28149333 |
| 13 | KDR | 1.99858640 |
| 14 | WEE1 | 1.99155038 |
| 15 | TRIB3 | 1.91912477 |
| 16 | TAOK2 | 1.87439691 |
| 17 | MAPKAPK5 | 1.81511282 |
| 18 | SCYL2 | 1.76097432 |
| 19 | BLK | 1.71023581 |
| 20 | SMG1 | 1.66150401 |
| 21 | MAP4K1 | 1.62298630 |
| 22 | VRK1 | 1.57024676 |
| 23 | ARAF | 1.51544748 |
| 24 | ACVR1B | 1.44072374 |
| 25 | STK39 | 1.41355483 |
| 26 | KIT | 1.41291617 |
| 27 | SIK1 | 1.37816880 |
| 28 | LMTK2 | 1.33235055 |
| 29 | MYLK | 1.27993308 |
| 30 | OXSR1 | 1.27626849 |
| 31 | TBK1 | 1.25578486 |
| 32 | TEC | 1.23566612 |
| 33 | ZAP70 | 1.22808837 |
| 34 | DAPK1 | 1.22806378 |
| 35 | IRAK3 | 1.22179066 |
| 36 | EPHA2 | 1.21013505 |
| 37 | LIMK1 | 1.19970614 |
| 38 | BRSK2 | 1.19876563 |
| 39 | MAP3K3 | 1.18996242 |
| 40 | TYK2 | 1.17172466 |
| 41 | ABL2 | 1.13713869 |
| 42 | TXK | 1.12440516 |
| 43 | MAP3K12 | 1.06545167 |
| 44 | IKBKE | 1.06253233 |
| 45 | MAP2K3 | 1.05358204 |
| 46 | SIK3 | 1.02866616 |
| 47 | IRAK4 | 1.02560941 |
| 48 | RIPK4 | 1.00402957 |
| 49 | TESK1 | 0.99308593 |
| 50 | CDK19 | 0.99302494 |
| 51 | LRRK2 | 0.98488126 |
| 52 | NME1 | 0.95166808 |
| 53 | NEK9 | 0.94999626 |
| 54 | MET | 0.94011169 |
| 55 | PIK3CG | 0.92265612 |
| 56 | RPS6KB2 | 0.91816339 |
| 57 | TGFBR2 | 0.90867941 |
| 58 | JAK3 | 0.89622760 |
| 59 | ICK | 0.89339352 |
| 60 | MAPKAPK3 | 0.89103690 |
| 61 | PLK4 | 0.87180686 |
| 62 | MST1R | 0.86604407 |
| 63 | IKBKB | 0.86109712 |
| 64 | PTK2 | 0.85101609 |
| 65 | MKNK1 | 0.84467853 |
| 66 | CSNK1G3 | 0.84364669 |
| 67 | PRPF4B | 0.83755035 |
| 68 | MUSK | 0.82673102 |
| 69 | BTK | 0.82099222 |
| 70 | TSSK6 | 0.81630212 |
| 71 | CSF1R | 0.80042214 |
| 72 | MAP3K1 | 0.78495739 |
| 73 | GRK7 | 0.78010629 |
| 74 | PDK2 | 0.77818589 |
| 75 | DDR2 | 0.77412487 |
| 76 | RPS6KA4 | 0.76677912 |
| 77 | EIF2AK2 | 0.76009719 |
| 78 | BMX | 0.74826057 |
| 79 | SRPK1 | 0.74702476 |
| 80 | STK10 | 0.73392045 |
| 81 | MATK | 0.73090017 |
| 82 | ERBB4 | 0.72365761 |
| 83 | TAOK1 | 0.71337496 |
| 84 | RPS6KA5 | 0.71003344 |
| 85 | MAP3K14 | 0.70421203 |
| 86 | TRPM7 | 0.69707502 |
| 87 | EPHB2 | 0.69672643 |
| 88 | BCR | 0.69613353 |
| 89 | MAP3K11 | 0.67643928 |
| 90 | MAP3K8 | 0.67111798 |
| 91 | NEK1 | 0.67026801 |
| 92 | RIPK1 | 0.66858022 |
| 93 | PKN2 | 0.66239916 |
| 94 | TLK1 | 0.66215420 |
| 95 | EPHB1 | 0.66145586 |
| 96 | TGFBR1 | 0.66075470 |
| 97 | ERN1 | 0.66003357 |
| 98 | CSNK1G1 | 0.65914901 |
| 99 | FGFR4 | 0.65760034 |
| 100 | PRKCI | 0.65481585 |
| 101 | LYN | 0.63098384 |
| 102 | BMPR1B | 0.63094705 |
| 103 | DAPK3 | 0.62868839 |
| 104 | CAMKK2 | 0.60440597 |
| 105 | IRAK2 | 0.59774371 |
| 106 | TIE1 | 0.57635131 |
| 107 | ZAK | 0.56239727 |
| 108 | PIM1 | 0.55470140 |
| 109 | PDPK1 | 0.54983237 |
| 110 | CSNK2A1 | 0.54477406 |
| 111 | FER | 0.54425161 |
| 112 | ILK | 0.53714763 |
| 113 | LCK | 0.52844964 |
| 114 | BRAF | 0.52016167 |
| 115 | CAMK2G | 0.51961892 |
| 116 | CSNK1A1L | 0.48807530 |
| 117 | NEK6 | 0.48476844 |
| 118 | PDK3 | 0.47791527 |
| 119 | PDK4 | 0.47791527 |
| 120 | SYK | 0.47724242 |
| 121 | PAK1 | 0.47710997 |
| 122 | MOS | 0.47419466 |
| 123 | STK4 | 0.46691155 |
| 124 | FGR | 0.46180874 |
| 125 | AURKB | 0.45881838 |
| 126 | NUAK1 | 0.45685691 |
| 127 | CDK8 | 0.44626131 |
| 128 | PRKG2 | 0.43985044 |
| 129 | CSK | 0.43934512 |
| 130 | AURKA | 0.43526648 |
| 131 | CLK1 | 0.42292101 |
| 132 | MAPK4 | 0.41517416 |
| 133 | MAPKAPK2 | 0.40167886 |
| 134 | PTK6 | 0.36546530 |
| 135 | TTN | 0.35433839 |
| 136 | CDC42BPA | 0.34801158 |
| 137 | CDK7 | 0.34151565 |
| 138 | BRSK1 | 0.30247346 |
| 139 | AKT2 | 0.27102736 |
| 140 | EEF2K | 0.26921454 |
| 141 | MAP3K13 | 0.26302313 |
| 142 | LATS2 | 0.25866648 |
| 143 | GSK3A | 0.25501621 |
| 144 | PRKD3 | 0.25049739 |
| 145 | MAPK11 | 0.23232033 |
| 146 | ALK | 0.22874112 |
| 147 | MAP2K6 | 0.22388962 |
| 148 | CAMK2D | 0.21557218 |
| 149 | NTRK1 | 0.21424875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.61334404 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.02929163 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.98815487 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.75729870 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.59581143 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.21720798 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.21090954 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.15969055 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.12695262 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06963717 |
| 11 | Galactose metabolism_Homo sapiens_hsa00052 | 2.04475437 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.01538443 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.00543546 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.89320541 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84678151 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73770402 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.73504016 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.69887094 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.69393229 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.68776704 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63411625 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61259795 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59894438 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56711045 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54020567 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.52694282 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52471090 |
| 28 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49059615 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47321027 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46201074 |
| 31 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.44438362 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.42375972 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41723511 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41364012 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40886368 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37375476 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36734186 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35593910 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32273652 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31013575 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.29009681 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27137839 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26630749 |
| 44 | Mismatch repair_Homo sapiens_hsa03430 | 1.22600306 |
| 45 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.18991727 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18578658 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18480199 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18225411 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18087747 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18087557 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.17750625 |
| 52 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17734377 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17256207 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11402633 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11138528 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.10439392 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10325412 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06238100 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05339305 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05232012 |
| 61 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04048540 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03499683 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03051384 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 1.00211689 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99803059 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99729302 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.98523931 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97582537 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96439819 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94583567 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93572026 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.93334924 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91112494 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89894676 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88927992 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.88173813 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87142639 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.86770241 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86164737 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85710456 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85256942 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85048250 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84730307 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84323849 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.81226749 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78655302 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77281831 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.76604371 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76552703 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76210458 |
| 91 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75969800 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75011999 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74507232 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.72320440 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71650395 |
| 96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71565624 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71295171 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69894750 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.68105671 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66612377 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.66338835 |
| 102 | Spliceosome_Homo sapiens_hsa03040 | 0.65535726 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.64905855 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64719943 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62595964 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61359223 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60715343 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59993523 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59509673 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59191701 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.58205398 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.57446319 |
| 113 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56334668 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55121789 |
| 115 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54836254 |
| 116 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53547222 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52930547 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52015303 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51233432 |
| 120 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50974960 |
| 121 | RNA transport_Homo sapiens_hsa03013 | 0.50590242 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50039769 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.48539094 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.48397892 |
| 125 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48346631 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47571309 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46819984 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.46565828 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45096919 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44121546 |
| 131 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43832823 |
| 132 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39688047 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39314240 |
| 134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39115566 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.37619113 |
| 136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36912302 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36583362 |
| 138 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36487474 |
| 139 | Allograft rejection_Homo sapiens_hsa05330 | 0.34058106 |
| 140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33031227 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32314932 |

